|
| Status |
Public on Dec 31, 2011 |
| Title |
270_02 |
| Sample type |
RNA |
| |
|
| Source name |
Uveal melanoma
|
| Organism |
Homo sapiens |
| Characteristics |
cell line: GNAQ mutant
treatment: pre treatment
|
| Treatment protocol |
Untreated versus 8h Selumetinib
|
| Growth protocol |
RPMI 10% FBS
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Total RNA was extracted from cells using Trizol lysis reagent
|
| Label |
Biotin
|
| Label protocol |
Per manufacturer's instructions
|
| |
|
| Hybridization protocol |
Per manufacturer's instructions
|
| Scan protocol |
scanned on the BeadArray Reader, iScan system.
|
| Data processing |
Signal intensity generated with Illumina iScan Control software and expression was quantile normalized using the preprocessCore library in R (R 2.10.1, preprocessCore version 1.8.0).
|
| |
|
| Submission date |
Nov 13, 2011 |
| Last update date |
May 17, 2012 |
| Contact name |
Brian Denton |
| E-mail(s) |
[email protected]
|
| Organization name |
Memorial Sloan-Kettering Cancer Center
|
| Department |
Epidemiology and Biostatistics
|
| Street address |
307 E. 63rd Street
|
| City |
New York |
| State/province |
NY |
| ZIP/Postal code |
10065 |
| Country |
USA |
| |
|
| Platform ID |
GPL10558 |
| Series (1) |
| GSE33655 |
Whole-transcript expression data for uveal melanoma |
|
